127 related articles for article (PubMed ID: 38546331)
1. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
Ruike Y; Suzuki S; Yokote K
Clin Nucl Med; 2024 May; 49(5):419-426. PubMed ID: 38546331
[TBL] [Abstract][Full Text] [Related]
2. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
5. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
[TBL] [Abstract][Full Text] [Related]
6. [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].
Padberg BC; Rordorf T; Suter SL; Pfeiffer D; Wild D; Schröder S
Pathologe; 2007 Jul; 28(4):281-4. PubMed ID: 16673076
[TBL] [Abstract][Full Text] [Related]
7. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
8. Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.
Martiniova L; Perera SM; Brouwers FM; Alesci S; Abu-Asab M; Marvelle AF; Kiesewetter DO; Thomasson D; Morris JC; Kvetnansky R; Tischler AS; Reynolds JC; Fojo AT; Pacak K
Endocr Relat Cancer; 2011 Feb; 18(1):143-57. PubMed ID: 21098082
[TBL] [Abstract][Full Text] [Related]
9. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
[TBL] [Abstract][Full Text] [Related]
10. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
[TBL] [Abstract][Full Text] [Related]
12. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
[TBL] [Abstract][Full Text] [Related]
13. [Limitations of scintigraphy using metaiodobenzylguanidine for locating pheochromocytomas. Apropos of 2 cases].
Garnier LF; Cosnay P; Moquet B; Doll G; Robin P; Baulieu JL; Fauchier JP; Raynaud PA; Vandooren M; Brochier M
Ann Cardiol Angeiol (Paris); 1988 Mar; 37(3):147-51. PubMed ID: 3364932
[TBL] [Abstract][Full Text] [Related]
14. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
[TBL] [Abstract][Full Text] [Related]
15. Detecting pheochromocytoma: defining the most sensitive test.
Guller U; Turek J; Eubanks S; Delong ER; Oertli D; Feldman JM
Ann Surg; 2006 Jan; 243(1):102-7. PubMed ID: 16371743
[TBL] [Abstract][Full Text] [Related]
16. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
17. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of MIBG scintigraphy and computerized tomography in the localization of pheochromocytomas].
Charbonnel B; Chatal JF
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):980-4. PubMed ID: 3099719
[TBL] [Abstract][Full Text] [Related]
19. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
